Cell Impact AB (publ) (STO:CI)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1160
-0.0040 (-3.33%)
At close: Mar 27, 2026

Cell Impact AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
5.5737.3347.2677.4271.35
Other Revenue
0.120.60.40.910.45
5.6937.9247.6678.3281.8
Revenue Growth (YoY)
-85.01%-20.44%-39.14%-4.26%179.09%
Cost of Revenue
10.6631.9121.8139.8746.92
Gross Profit
-4.976.0125.8538.4534.88
Selling, General & Admin
46.9662.27120.04124102.68
Other Operating Expenses
3.111.51.641.530.05
Operating Expenses
122.94105.03145.34141.91112.92
Operating Income
-127.91-99.02-119.49-103.47-78.04
Interest Expense
-4.41-2.56-3.05-1.54-1.69
Interest & Investment Income
0.211.471.180.86-
Currency Exchange Gain (Loss)
-0.23-0.23---
Other Non Operating Income (Expenses)
0.37--0-0-0
Pretax Income
-131.98-100.35-121.36-104.15-79.73
Income Tax Expense
0.010.090.040.070.12
Net Income
-131.98-100.43-121.4-104.22-79.85
Net Income to Common
-131.98-100.43-121.4-104.22-79.85
Shares Outstanding (Basic)
1696181186
Shares Outstanding (Diluted)
1696181186
Shares Change (YoY)
-72.65%5538.36%44.78%27.89%17.66%
EPS (Basic)
-0.78-0.16-11.07-13.76-13.49
EPS (Diluted)
-0.78-0.16-11.07-13.76-13.49
Free Cash Flow
-47.29-74.64-156.29-168.37-139.05
Free Cash Flow Per Share
-0.28-0.12-14.26-22.23-23.48
Gross Margin
-87.41%15.86%54.24%49.09%42.64%
Operating Margin
-2249.63%-261.12%-250.70%-132.11%-95.40%
Profit Margin
-2321.21%-264.84%-254.71%-133.07%-97.62%
Free Cash Flow Margin
-831.69%-196.82%-327.92%-214.98%-169.99%
EBITDA
-105.59-80.16-106.32-92.29-72.3
EBITDA Margin
--211.38%-223.07%-117.84%-88.39%
D&A For EBITDA
22.3218.8613.1711.185.74
EBIT
-127.91-99.02-119.49-103.47-78.04
EBIT Margin
--261.12%-250.70%-132.11%-95.40%
Revenue as Reported
2.0726.8548.5893.0381.8
Source: S&P Global Market Intelligence. Standard template. Financial Sources.